LakeShore Biopharma (LSB) Stock Chart & Stock Price History $0.81 +0.01 (+0.93%) Closing price 08/12/2025 03:59 PM EasternExtended Trading$0.80 -0.01 (-1.23%) As of 08/12/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LakeShore Biopharma Stock Price Performance The LakeShore Biopharma (LSB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 80.24%, with a year-to-date return of -76.59%. In the past month, the stock has decreased 25.00%, reflecting recent market activity. As of the latest close, LakeShore Biopharma traded at $0.81 with a market cap of $16.82 million and volume of 11,790 shares. Receive LSB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LakeShore Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+15.71%1 Month Performance-25.00%3 Month Performance-30.18%Year-To-Date Performance-76.59%1 Year Performance-80.24% LSB Stock Chart for Wednesday, August, 13, 2025 LSB Chart by TradingView LakeShore Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/12/2025$0.80$0.81+0.93%$0.81$0.7311,790 shs$16.82 million08/11/2025$0.70$0.80+14.64%$0.81$0.6862,312 shs$7.47 million08/08/2025$0.68$0.70+3.55%$0.71$0.6523,212 shs$0.0008/07/2025$0.66$0.68+2.04%$0.68$0.59124,980 shs$6.17 million08/06/2025$0.73$0.66-9.25%$0.78$0.6585,872 shs$0.0008/05/2025$0.73$0.73+0.62%$0.74$0.7210,414 shs$0.0008/04/2025$0.73$0.73-0.62%$0.74$0.729,379 shs$6.75 million08/01/2025$0.82$0.73-10.98%$0.84$0.7061,718 shs$6.80 million07/31/2025$0.76$0.82+8.58%$0.90$0.7996,910 shs$8.38 million07/30/2025$0.90$0.76-16.14%$1.00$0.74146,768 shs$8.68 million Get the Latest News and Ratings for LSB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LakeShore Biopharma and its competitors with MarketBeat's FREE daily newsletter. 07/29/2025$0.93$0.90-3.43%$1.17$0.90403,024 shs$8.38 million07/28/2025$1.15$0.93-18.91%$1.15$0.92104,710 shs$10.70 million07/25/2025$1.31$1.15-12.21%$1.29$1.1557,619 shs$11.45 million07/24/2025$1.23$1.31+6.50%$1.35$1.2456,732 shs$10.98 million07/23/2025$1.18$1.23+4.24%$1.25$1.1837,279 shs$11.45 million07/22/2025$1.08$1.18+9.26%$1.23$1.07127,030 shs$9.68 million07/21/2025$1.04$1.08+3.84%$1.20$1.03164,857 shs$9.68 million07/18/2025$1.11$1.04-6.30%$1.15$1.02146,390 shs$10.42 million07/17/2025$1.12$1.11-0.89%$1.16$1.0916,995 shs$10.33 million07/16/2025$1.06$1.12+5.66%$1.13$1.0190,990 shs$10.33 million07/15/2025$1.11$1.06-4.50%$1.09$1.03112,688 shs$10.05 million07/14/2025$1.08$1.11+2.78%$1.15$1.02138,561 shs$10.05 million Related Companies 180 Life Sciences Stock Chart 4D pharma Stock Chart Aesther Healthcare Acquisition Stock Chart Ainos Stock Chart Alvotech Stock Chart Atlantic Coastal Acquisition Corp. II Stock Chart Biofrontera Stock Chart biote Stock Chart BriaCell Therapeutics Stock Chart Celularity Stock Chart Receive LSB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LakeShore Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LSB) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LakeShore Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share LakeShore Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access